Medicines Development for Global Health (MDGH) is an independent not-for-profit company dedicated to the development of medicines for those who need them most. The company addresses health inequity by researching, developing, and delivering new and improved medicines for diseases disproportionately affecting low- and middle-income countries. In June 2018 we received FDA approval of moxidectin, the first new treatment for River...
Medicines Development for Global Health (MDGH) is an independent not-for-profit company dedicated to the development of medicines for those who need them most. The company addresses health inequity by researching, developing, and delivering new and improved medicines for diseases disproportionately affecting low- and middle-income countries. In June 2018 we received FDA approval of moxidectin, the first new treatment for River Blindness in more than 30 years.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.